Diabetes is a pressing health concern in India, with an estimated 100 million individuals struggling with Type 2 diabetes, and another 130 million on the brink of pre-diabetes according to the country's health ministry, the demand for innovative diabetes management solutions has never been more urgent.

Recognizing this, Sugar.fit, an Indian health-tech startup specializing in Type 2 and pre-diabetes management and reversal, recently closed an $11 million Series A funding round.

This fresh infusion of $11 million will fuel Sugar.fit's ambitious expansion plans, which include diversifying their product offerings and establishing a physical presence across India. Furthermore, it will enable the company to intensify its research and development efforts in the field of diabetes management.

This investment round was spearheaded by MassMutual Ventures, with additional support from existing backers including Cure.fit, Tanglin Venture Partners, and Endiya Partners.

Founded in 2021, Sugar.fit adopts a comprehensive approach to diabetes management. It combines hardware, software, and analytics to deliver personalized programs and lasting behavioural changes to foster healthier outcomes.

Before securing this Series A funding, Sugar.fit had secured $10 million in a seed funding round, and has since shown exceptional growth. In the last 18 months, the company experienced an eightfold increase in its paid subscribers. At present, it boasts a user base exceeding 25,000 individuals who have benefited from its platform.

As the battle against diabetes in India rages on, Sugar.fit is well-positioned to play a pivotal role in transforming the health of millions.